Filing Details
- Accession Number:
- 0001127602-13-007105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-20 17:04:31
- Reporting Period:
- 2013-02-19
- Filing Date:
- 2013-02-20
- Accepted Time:
- 2013-02-20 17:04:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1126490 | F Richard Pops | Connaught House 1 Burlington Road Dublin 4 Ireland | Director And Ceo, Alkermes Plc | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2013-02-19 | 50,000 | $9.97 | 471,047 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-02-19 | 50,000 | $20.96 | 421,047 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2013-02-19 | 50,000 | $0.00 | 50,000 | $9.97 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,250 | 2013-04-25 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.86 to $21.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- These options are fully vested in accordance with their terms.